Clinical Trials · NCT00833248
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 246
- Start date
- Apr 2009
- Locations
- 66 sites, 7 countries
- Primary endpoint
- Change From Baseline in Prostate Size Based on Trans Rectal Ultra Sound (TRUS) at Week 12 (Full Analysis Set)